Abiopharma

News list

📋 ABHMC II, LLC (Shareholder) plans to sell 100K shares of Immunome, Inc. (at $21.04 each, total $2.1M) Filed: Jun 30, 2026 | ID: 046298

Full text

News bot June 30, 2026, 9:21 p.m.
📋 Form 144 Filing: ABHMC II, LLC

Company: Immunome, Inc.

Filing Date: 2026-06-30

Relationship: Shareholder
Planned Sale Details:
- Security: Common
- Shares to be Sold: 100,000
- Price per Share: $21.04
- Total Value: $2,104,000.00
- Planned Sale Date: 2026-06-30
- Broker: Merrill Lynch
- Exchange: Nasdaq
Additional Information:
- SEC File Number: 001-39580
- Issuer Contact Phone: 4259397410
- Issuer Address: 18702 N. CREEK PARKWAY, SUITE 100, BOTHEL, WA, 98011
- Broker Address: 555 California Street, 18th Floor, San Francisco, CA, 94104
- Shares Outstanding: 113250394.0
- Number of Securities to be Sold: 1
- Signature: James B. Graham
- Plan Adoption Dates: 2026-03-31